0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Is Specimen Mammography Beneficial?—Invited Critique

Douglas Reintgen, MD
Arch Surg. 2000;135(9):1089. doi:10.1001/archsurg.135.9.1089.
Text Size: A A A
Published online

Extract

One hundred sixty-four patients underwent 165 needle/dye-localization biopsies in the reported series from the City of Hope Cancer Center (Duarte, Calif). The authors estimate that specimen mammography (SM) was only beneficial in 1.8% of the patients and no cancer was missed. On the other hand, SM was incorrect in 24.8% of patients and added $60,522 in costs to the institution with an additional 55 hours of operating time.

The main reason given in support of SM is that it allows the surgeon to judge the adequacy of the excision and perhaps avoid reexcisions for negative margins and for medical-legal purposes. Specimen mammography is incorrect in up to 44% of cases, resulting in the unnecessary excision of tissue, missed tumors, and a false sense of security for the surgeon. Specimen mammography is considered wrong when there is a discordance between its outcome and the pathological and postoperative mammographic finding. The American College of Radiology (Reston, Va) judge it to be the standard of care for needle-localization biopsy.

Topics

mammography

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination
Effectiveness of CBE

The Rational Clinical Examination
Table 8-7 Mammography Screening Is Increasing as Clinical Breast Examination Is Decreasing

brightcove.createExperiences();